(E)-7-(cyclohexylamino)-3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(1-(4-(dimethylamino)but-2-enoyl)piperidin-4-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one

ID: ALA4088313

Chembl Id: CHEMBL4088313

PubChem CID: 135317844

Max Phase: Preclinical

Molecular Formula: C31H41Cl2N7O4

Molecular Weight: 646.62

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COc1cc(OC)c(Cl)c(N2Cc3cnc(NC4CCCCC4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl

Standard InChI:  InChI=1S/C31H41Cl2N7O4/c1-37(2)14-8-11-25(41)38-15-12-22(13-16-38)40-29-20(18-34-30(36-29)35-21-9-6-5-7-10-21)19-39(31(40)42)28-26(32)23(43-3)17-24(44-4)27(28)33/h8,11,17-18,21-22H,5-7,9-10,12-16,19H2,1-4H3,(H,34,35,36)/b11-8+

Standard InChI Key:  AOYJOQPVLIISJS-DHZHZOJOSA-N

Alternative Forms

1. Parent:

   

   ALA4088313

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 646.62

Molecular Weight (Monoisotopic): 645.2597

AlogP: 5.60

#Rotatable Bonds: 9

Polar Surface Area: 103.37

Molecular Species: BASE

HBA: 8

HBD: 1

#RO5 Violations: 2

HBA (Lipinski): 11

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 3

CX Acidic pKa: ┄

CX Basic pKa: 8.81

CX LogP: 3.94

CX LogD: 2.52

Aromatic Rings: 2

Heavy Atoms: 44

QED Weighted: 0.35

Np Likeness Score: -0.63

References

1. Li X, Guise CP, Taghipouran R, Yosaatmadja Y, Ashoorzadeh A, Paik WK, Squire CJ, Jiang S, Luo J, Xu Y, Tu ZC, Lu X, Ren X, Patterson AV, Smaill JB, Ding K..  (2017)  2-Oxo-3, 4-dihydropyrimido[4, 5-d]pyrimidinyl derivatives as new irreversible pan fibroblast growth factor receptor (FGFR) inhibitors.,  135  [PMID:28521156] [10.1016/j.ejmech.2017.04.049]

Source

Source(1):

• Scientific Literature